Favorable factors for re-treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus
-
- TAMORI Akihiro
- Department of Hepatology, Osaka City University Graduate School of Medicine
-
- KIOKA Kiyohide
- Department of Hepatology Osaka City General Hospital
-
- KURAI Osamu
- Department of Gastroenterology and Hepatology, Osaka City Juso Hospital
-
- SAKAGUCHI Hiroki
- Internal Medicine, Izumi Municipal Hospital
-
- ENOMOTO Masaru
- Department of Hepatology, Osaka City University Graduate School of Medicine
-
- FUJII Hideki
- Department of Hepatology, Osaka City University Graduate School of Medicine
-
- KOBAYASHI Sawako
- Department of Hepatology, Osaka City University Graduate School of Medicine
-
- IWAI Shuji
- Department of Hepatology, Osaka City University Graduate School of Medicine
-
- MORIKAWA Hiroyasu
- Department of Hepatology, Osaka City University Graduate School of Medicine
-
- YAMAGUCHI Seiko
- Department of Gastroenterology and Hepatology, Osaka City Juso Hospital
-
- KAWASAKI Yasuko
- Department of Hepatology Osaka City General Hospital
-
- OKA Hiroko
- Department of Gastroenterology and Hepatology, Osaka City Juso Hospital
-
- TANAKA Yasuhito
- Department of Virology & Liver Unit, Nagoya City University Graduate School of Medical Sciences
-
- KAWADA Norifumi
- Department of Hepatology, Osaka City University Graduate School of Medicine
この論文をさがす
収録刊行物
-
- Hepatology research : the official journal of the Japan Society of Hepatology
-
Hepatology research : the official journal of the Japan Society of Hepatology 41 (12), 1169-1177, 2011-12-01
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1573950400906985728
-
- NII論文ID
- 10031144195
-
- NII書誌ID
- AA11140867
-
- ISSN
- 13866346
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles